Genetic products differentially expressed in tumors

Details for Australian Patent Application No. 2008258158 (hide)

Owner Gaynmed Pharmaceuticals AG

Inventors Koslowski, Michael; Tureci, Ozlem; Sahin, Ugur

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008258158

Parent 2003219045

Filing date 16 December 2008

Wipo publication date 15 January 2009

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

8 January 2009 Complete Application Filed

15 January 2009 Application Open to Public Inspection

  Published as AU-A-2008258158

29 January 2009 Corrigenda

  Applications OPI - Name Index Under the Name Gaynmed Pharmaceuticals AG, Application No. 2008258158, under INID (54) correct the title to read Genetic products differentially expressed in tumors and use thereof

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258159-Nozzle functionality detection of inkjet printers

2008258157-Mask Assembly